What this bill does
AI plain-language summaryThis bill sets new rules for how Medicare prescription drug plans work with pharmacies and the companies that manage drug benefits, known as pharmacy benefit managers (PBMs). It requires the government to create standards for contracts between drug plan sponsors and pharmacies, and it limits PBMs to only earning flat service fees, meaning they must hand over any extra money they receive. PBMs would also have to report detailed information about drug costs, claims, and related data to drug plan sponsors and the government, and they can be audited and fined if they don't follow the rules. The bill also requires the government to report on pharmacies that are the only option in their area, and most of these changes would start in 2028.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
No comments yet. Be the first.